search
Back to results

Mass Spectrometry Based Cutoffs for Cortisol After Stimulation Tests

Primary Purpose

Adrenal Insufficiency

Status
Unknown status
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Synachten
Sponsored by
Haukeland University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Adrenal Insufficiency

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy individuals not using any corticosteroids .
  • Patients with clinical suspicion of primary or secondary adrenal insufficiency. -Patient suspicious of having an enzyme defect ( 21 hydroxylase deficiency) giving hirsutism.

Exclusion Criteria:

-Use of corticosteroids.

Sites / Locations

  • Haukeland University hopsitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Synacthen

Arm Description

The patient get Synacthen to stimulate the adrenals to produce cortisol

Outcomes

Primary Outcome Measures

Define a cutoff level for serum cortisol after stimulation with synacthen or hypoglycemia in healthy control persons.
s-cortisol

Secondary Outcome Measures

Define a cutoff level for serum 17-OH-progesterone after stimulation with synacthen or hypoglycemia in healthy control persons.
s-17-OH-progesterone
Define a cutoff level for saliva cortisol after stimulation with synacthen or hypoglycemia in healthy control persons.
saliva cortisol
Define a cutoff level for saliva 17-OH-progesterone after stimulation with synacthen or hypoglycemia in healthy control persons.
saliva 17-OH-progesterone

Full Information

First Posted
June 14, 2016
Last Updated
August 14, 2017
Sponsor
Haukeland University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02818660
Brief Title
Mass Spectrometry Based Cutoffs for Cortisol After Stimulation Tests
Official Title
Mass Spectrometry Based Cutoffs for Cortisol and 17-hydroxy-progesterone (17-OH-progesterone) After Stimulation Tests for Primary and Secondary Adrenal Insufficiency.
Study Type
Interventional

2. Study Status

Record Verification Date
August 2017
Overall Recruitment Status
Unknown status
Study Start Date
May 2016 (undefined)
Primary Completion Date
December 2017 (Anticipated)
Study Completion Date
May 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Haukeland University Hospital

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
There are two main stimulation tests used to decide if a patient has cortisol deficiency. It is the "synacthen test", were we stimulate the patient with intramuscular or intravenous synacthen ( ACTH) to see how much cortisol the adrenals are capable of producing, and it is the "Insulin hypoglycemia test" were we give the patient insulin to provoke a hypoglycemia, and look at the adrenal response to that stimulus. The cut off values for a normal response is based on old immunological assays no longer in use. Assays with a lot of interference and cross reactivity leading to measurement of higher values for cortisol than what we measure on the highly specific LCMS/MS ( Liquid chromatography mass spectrometry methode) that we are using for cortisol today. So, there is a need for new cut off values for a normal response to such tests. The purpose of this study is to produce such new cutoff values by performing the test in 120 healthy controls. We also want to perform the test in patient groups normally going trough this tests according to the same protocol as the control persons, to evaluate the new cutoffs in different patient groups.
Detailed Description
120 healthy controls will perform an intravenous synacthen test in our out patient clinic. We register anthropometric data, and take basal blood screening to assure they are healthy. We take basal blood and saliva samples right before start of the test ( called 0-samples). Then they get intravenous synacthen, and we take new samples at 30 minutes and 60 minutes. They are observed during the procedure. We will then calculate a new cut off value for cortisol after the test, based on the 2.5 percentile for cortisol in this population. We will also calculate the same for 17-OH-progesterone, a parameter we also look at after synacthen test in som patient groups ( patients with hirsutism, who are suspicious of having an enzyme defect in the cortisol synthesis cascade). The saliva samples will also be analyzed for cortisol and 17-OH-progesterone, to evaluate if it is possible to use saliva instead of blood samples in synacthen tests in the future. The advantage of using saliva samples is that they can be used also in patients with elevated amount of cortisol binding globulin (CBG), because it measure the free hormone that is biological active ( not both the free and the protein bound, as we measure in serum samples). This is important in patients on estrogens , and in pregnant women, that have large amount of CBG.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Adrenal Insufficiency

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Synacthen
Arm Type
Experimental
Arm Description
The patient get Synacthen to stimulate the adrenals to produce cortisol
Intervention Type
Drug
Intervention Name(s)
Synachten
Other Intervention Name(s)
tetracosactide
Intervention Description
To stimulate the adrenals to increase the cortisol Production as much as possible
Primary Outcome Measure Information:
Title
Define a cutoff level for serum cortisol after stimulation with synacthen or hypoglycemia in healthy control persons.
Description
s-cortisol
Time Frame
2 year
Secondary Outcome Measure Information:
Title
Define a cutoff level for serum 17-OH-progesterone after stimulation with synacthen or hypoglycemia in healthy control persons.
Description
s-17-OH-progesterone
Time Frame
2 year
Title
Define a cutoff level for saliva cortisol after stimulation with synacthen or hypoglycemia in healthy control persons.
Description
saliva cortisol
Time Frame
2 year
Title
Define a cutoff level for saliva 17-OH-progesterone after stimulation with synacthen or hypoglycemia in healthy control persons.
Description
saliva 17-OH-progesterone
Time Frame
2 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy individuals not using any corticosteroids . Patients with clinical suspicion of primary or secondary adrenal insufficiency. -Patient suspicious of having an enzyme defect ( 21 hydroxylase deficiency) giving hirsutism. Exclusion Criteria: -Use of corticosteroids.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Grethe Åstrøm Ueland, MD
Phone
+4790950021
Email
geas@helse-bergen.no
First Name & Middle Initial & Last Name or Official Title & Degree
Eystein Husebye, MD, Prof.
Phone
+47559750000
Email
eyhu@helse-bergen.no
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Grethe Åstrøm Ueland, MD
Organizational Affiliation
Haukeland University Hopsital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Haukeland University hopsital
City
Bergen
ZIP/Postal Code
5019
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Grethe Ueland, MD
Phone
+4790950021
Email
geas@helse-bergen.no
First Name & Middle Initial & Last Name & Degree
Hrafnkell Thordasron, MD
Phone
+4755972955
Email
hraf@helse-bergen.no

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Mass Spectrometry Based Cutoffs for Cortisol After Stimulation Tests

We'll reach out to this number within 24 hrs